Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B

被引:26
|
作者
Amato, Valdir Sabbaga [1 ]
Tuon, Felipe Francisco [1 ]
Campos, Aleia [1 ]
Bacha, Helio Arthur [1 ]
Nicodemo, Antonio Carlos [1 ]
Neto, Vicente Amato [1 ]
Shikanai-Yasuda, Maria Aparecida [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil
关键词
D O I
10.1086/510494
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:311 / 312
页数:2
相关论文
共 50 条
  • [1] Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
    Tuon, Felipe Francisco
    Santos, Carolina Rocio
    Cieslinski, Juliette
    de Souza, Regina Maia
    Imamura, Rui
    Amato, Valdir Sabbaga
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2018, 60
  • [2] Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis
    Syriopoulou, V
    Daikos, GL
    Theodoridou, M
    Pavlopoulou, I
    Manolaki, AG
    Sereti, E
    Karamboula, A
    Papathanasiou, D
    Krikos, X
    Saroglou, G
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) : 560 - 566
  • [3] Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients
    Rocio, Carolina
    Amato, Valdir Sabbaga
    Camargo, Raphael A.
    Tuon, Felipe F.
    Nicodemo, Antonio Carlos
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2014, 108 (03) : 176 - 178
  • [4] Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis
    Wortmann, GW
    Fraser, SL
    Aronson, NE
    Davis, C
    Miller, RS
    Jackson, JD
    Oster, CN
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 1006 - 1007
  • [5] Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
    Jaafari, Mahmoud Reza
    Hatamipour, Mahdi
    Alavizadeh, Seyedeh Hoda
    Abbasi, Azam
    Saberi, Zahra
    Rafati, Sima
    Taslimi, Yasaman
    Mohammadi, Akram Miramin
    Khamesipour, Ali
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2019, 11 : 156 - 165
  • [6] Activity of amphotericin B in lipid emulsion in the initial treatment of canine leishmaniasis
    Lamothe, J
    JOURNAL OF SMALL ANIMAL PRACTICE, 2001, 42 (04) : 170 - 175
  • [7] Topical treatment of persistent cutaneous leishmaniasis with ethlanolic lipid amphotericin B
    Zvulunov, A
    Cagnano, E
    Frankenburg, S
    Barenholz, Y
    Vardy, D
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (06) : 567 - 569
  • [8] Amphotericin B lipid complex - In visceral leishmaniasis
    Goldsmith, DR
    Perry, CM
    DRUGS, 2004, 64 (17) : 1905 - 1911
  • [9] Amphotericin B Lipid ComplexIn Visceral Leishmaniasis
    David R. Goldsmith
    Caroline M. Perry
    Drugs, 2004, 64 : 1905 - 1911
  • [10] Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review
    Mosimann, Vincent
    Neumayr, Andreas
    Paris, Daniel H.
    Blum, Johannes
    ACTA TROPICA, 2018, 182 : 246 - 250